SanaCurrents on Aadi Bio’s (AADI) expansion of nab-Sirolimus to solid tumor cancers
Aadi Bioscience, Inc. (NASDAQ:AADI) Probability Sentiment SUMMARY Shortly after listing in mid-2021, Aadi Bioscience, Inc. [...]
Aadi Bioscience, Inc. (NASDAQ:AADI) Probability Sentiment SUMMARY Shortly after listing in mid-2021, Aadi Bioscience, Inc. [...]
Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) Probability Sentiment SUMMARY Syndax Pharmaceuticals, Inc. (NASDAQ:SNDX) is advancing the small [...]
X4 Pharmaceuticals, Inc. (NASDAQ:XFOR) Probability Sentiment SUMMARY X4 Pharmaceuticals, Inc.’s (NASDAQ:XFOR) mavorixafor posted impressive clinical [...]
Tarsus Pharmaceuticals, Inc. (NASDAQ:TARS) Probability Sentiment SUMMARY Staying focused on an FDA approval paid off [...]
Cyteir Therapeutics, Inc. (NASDAQ:CYT) Probability Sentiment SUMMARY Cyteir Therapeutics (NASDAQ:CYT) listed in June 2021, raising [...]
Seres Therapeutics, Inc. (NASDAQ:MCRB) Probability Sentiment SUMMARY Research in human microbiome treatments picked up rapidly [...]
Renovorx, Inc. (NASDAQ:RNXT) Probability Sentiment SUMMARY While pancreatic cancer has attracted many recent drug candidates [...]
Gossamer Bio, Inc. (NASDAQ:GOSS) Probability Sentiment SUMMARY The condition known as pulmonary arterial hypertension (PAH) [...]